ReferenceID 1722
Daidzein ameliorates diabetic retinopathy in experimental animals
Life Sci
AIM: The present study was designed to check the effect of daidzein in the management of diabetic retinopathy. MAIN METHODS: Streptozotocin at dose 55 mg/kg was used for inducing diabetes in rats. After 28 days of diabet
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 1722
- Evidence Id
- 18312
- Core Evidence Id
- 18312
- Source Reference Id
- 3428
- Herb2 Reference Id
- HBREF004225
- Subject Paper Key
- HBIN022577_33217441
- Pubmed Id
- 33217441
- Doi
- 10.1016/j.lfs.2020.118779
- Paper Title
- Daidzein ameliorates diabetic retinopathy in experimental animals
- Paper Abstract
- AIM: The present study was designed to check the effect of daidzein in the management of diabetic retinopathy. MAIN METHODS: Streptozotocin at dose 55 mg/kg was used for inducing diabetes in rats. After 28 days of diabetic induction, animals were treated with daidzein at dose 25, 50, and 100 mg/kg for the next 28 days. Electroretinography, estimation of plasma glucose, lactate dehydrogenase, aldose reductase, sorbitol dehydrogenase and oxidative stress parameters were performed at the end of the study. Histopathology of retina was carried out at the end of the study. KEY FINDINGS: Diabetic control animals showed a significant increase in levels of plasma glucose and plasma lactate dehydrogenase (p < 0.001). Treatment with daidzein at a dose of 50 and 100 mg/kg significantly reduced the elevated level of blood glucose (p < 0.01 and p < 0.01). Whereas, treatment with daidzein at a dose 100 mg/kg significantly reduced the elevated level of lactate dehydrogenase in plasma after 28 days of treatment (p < 0.01). Treatment with daidzein at a dose of 100 mg/kg significantly reduced the level of aldose reductase and sorbitol dehydrogenase (p < 0.01 and p < 0.001 respectively). Electroretinography revealed that daidzein treatment at a dose of 100 mg/kg significantly prevented the change in 'a' and 'b' wave amplitude and latency. Oxidative stress was also found to be significantly reduced after 28 days of daidzein treatment. Histopathological findings showed a reduction in retinal thickness after daidzein treatment. SIGNIFICANCE: Daidzein treatment protected retina from damage in hyperglycaemic conditions. Thus, Daidzein can be considered as an effective treatment option for diabetic retinopathy.
- Journal
- Life Sci
- Publish Year
- 2021
- Experiment Subject
- rat
- Experiment Type
- Animal Experiment
- Phenotype Related
- Diabetic Retinopathy; Diabetes
- Paper Title Cn
- Paper Title En
- Daidzein ameliorates diabetic retinopathy in experimental animals
- Bilingual Status
- semi_complete